159 related articles for article (PubMed ID: 24242681)
1. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
3. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
4. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
5. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
7. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
9. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigens as a risk factor for hematogenous recurrence of esophageal squamous cell carcinoma patients.
Makino T; Shimada Y; Maeda M; Komoto I; Imamura M
Oncol Rep; 2001; 8(5):981-5. PubMed ID: 11496302
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
Li K; Wang RW; Jiang YG; Zou YB; Guo W
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
[TBL] [Abstract][Full Text] [Related]
12. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
[TBL] [Abstract][Full Text] [Related]
14. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.
Tateno T; Ueno S; Hiwatashi K; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Sakoda M; Kubo F; Ishigami S; Shinchi H; Natsugoe S
Ann Surg Oncol; 2009 Feb; 16(2):440-6. PubMed ID: 19023628
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression.
Birner P; Jesch B; Friedrich J; Riegler M; Zacherl J; Hejna M; Wrba F; Schultheis A; Schoppmann SF
Ann Surg Oncol; 2011 Nov; 18(12):3330-7. PubMed ID: 21519917
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evidence of association between ghrelin expression and tumor growth in esophageal carcinoma.
Omoto I; Matsumoto M; Uchikado Y; Kita Y; Sakurai T; Sasaki K; Setoyama T; Okumura H; Owaki T; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jun; 34(6):2727-33. PubMed ID: 24922633
[TBL] [Abstract][Full Text] [Related]
18. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
19. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Yamamoto H; Itoh F; Iku S; Hosokawa M; Imai K
Clin Cancer Res; 2001 Apr; 7(4):896-900. PubMed ID: 11309339
[TBL] [Abstract][Full Text] [Related]
20. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
